CoronaVac Efficacy At 50-90% In Brazilian Trial -Sao Paulo Official

The CoronaVac COVID19 vaccine developed by China’s Sinovac Biotech Ltd showed efficacy between 50% and 90% in Brazilian trials, Sao Paulo's state health secretary said, and its Brazilian producer said full trial results will be released by Jan. 7.

from Top World News-
Read Rest:news18...